神経系患者モニタリングのグローバル市場(2022ー2031年):外傷、髄液管理、偏頭痛、脳卒中、脳波

• 英文タイトル:Neurology Patient Monitoring Market Forecast by Application (Trauma, CSF Management, Migraine, Stroke, EEG) and by Region - 2022 to 2032

Neurology Patient Monitoring Market Forecast by Application (Trauma, CSF Management, Migraine, Stroke, EEG) and by Region - 2022 to 2032「神経系患者モニタリングのグローバル市場(2022ー2031年):外傷、髄液管理、偏頭痛、脳卒中、脳波」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2301F0009
• 出版社/出版日:Transparency Market Research / 2022年11月8日
• レポート形態:英文、PDF、250ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥869,250 (USD5,795)▷ お問い合わせ
  Multi User¥1,319,250 (USD8,795)▷ お問い合わせ
  Corporate License¥1,769,250 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社では、世界の神経系患者モニタリング市場を調査対象とし、エグゼクティブサマリー、市場概要、市場背景、用途別分析(外傷、髄液管理、偏頭痛、脳卒中、脳波)、地域別分析(北米、中南米、アジア太平洋、中東/アフリカ、ヨーロッパ)、競争状況、企業情報などについて総合的に調査・分析をしました。なお、当書には、Medtronic、Integra LifeSciences、Raumedic AG、Sophysa、Spiegelberg GmbH、Natus Medical、Gaeltec Devices、Neural Analyticsなどの主要企業情報が含まれています。
・エグゼクティブサマリー
・市場概要
・市場背景

・世界の神経系患者モニタリング市場規模:用途別
- 外傷における市場規模
- 髄液管理における市場規模
- 偏頭痛における市場規模
- 脳卒中における市場規模
- 脳波における市場規模

・世界の神経系患者モニタリング市場規模:地域別
- 北米の神経系患者モニタリング市場規模
- 中南米の神経系患者モニタリング市場規模
- アジア太平洋の神経系患者モニタリング市場規模
- 中東/アフリカの神経系患者モニタリング市場規模
- ヨーロッパの神経系患者モニタリング市場規模

・競争状況
・企業情報

Neurology Patient Monitoring Market – Scope of Report
TMR’s report on the global neurology patient monitoring market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global neurology patient monitoring market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global neurology patient monitoring market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the neurology patient monitoring market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global neurology patient monitoring market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global neurology patient monitoring market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global neurology patient monitoring market.

The report delves into the competitive landscape of the global neurology patient monitoring market. Key players operating in the global neurology patient monitoring market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global neurology patient monitoring market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market neurology patient monitoring.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

レポート目次

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1.1. Producers
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
4. Global Neurology Patient Monitoring Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Neurology Patient Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Application
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032
5.3.1. Trauma
5.3.2. CSF Management
5.3.3. Migraine
5.3.4. Stroke
5.3.5. Hydrocephalus
5.3.6. EEG
5.3.7. Other Applications
5.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
5.5. Absolute $ Opportunity Analysis By Application, 2022-2032
6. Global Neurology Patient Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
6.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. East Asia
6.3.5. South Asia
6.3.6. Oceania
6.3.7. MEA
6.4. Market Attractiveness Analysis By Region
7. North America Neurology Patient Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
7.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
7.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
7.2.1. By Country
7.2.1.1. U.S.
7.2.1.2. Canada
7.2.2. By Application
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By Application
7.4. Key Takeaways
8. Latin America Neurology Patient Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Argentina
8.2.1.4. Rest of Latin America
8.2.2. By Application
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Application
8.4. Key Takeaways
9. Europe Neurology Patient Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. Italy
9.2.1.3. France
9.2.1.4. U.K.
9.2.1.5. Spain
9.2.1.6. Russia
9.2.1.7. BENELUX
9.2.1.8. Rest of Europe
9.2.2. By Application
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Application
9.4. Key Takeaways
10. East Asia Neurology Patient Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. China
10.2.1.2. Japan
10.2.1.3. South Korea
10.2.2. By Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Application
10.4. Key Takeaways
11. South Asia Neurology Patient Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. India
11.2.1.2. Thailand
11.2.1.3. Malaysia
11.2.1.4. Indonesia
11.2.1.5. Rest of South Asia
11.2.2. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Application
11.4. Key Takeaways
12. Oceania Neurology Patient Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. Australia
12.2.1.2. New Zealand
12.2.2. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Application
12.4. Key Takeaways
13. MEA Neurology Patient Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. GCC
13.2.1.2. Rest of MEA
13.2.2. By Application
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Application
13.4. Key Takeaways
14. Key Countries Neurology Patient Monitoring Market Analysis
14.1. U.S.
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Application
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Application
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Application
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Application
14.5. Argentina
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Application
14.6. Germany
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Application
14.7. Italy
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Application
14.8. France
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Application
14.9. U.K.
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Application
14.10. Spain
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Application
14.11. Russia
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Application
14.12. BENELUX
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Application
14.13. China
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Application
14.14. Japan
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Application
14.15. South Korea
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Application
14.16. India
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Application
14.17. Thailand
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Application
14.18. Malaysia
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2021
14.18.2.1. By Application
14.19. Indonesia
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2021
14.19.2.1. By Application
14.20. Australia
14.20.1. Pricing Analysis
14.20.2. Market Share Analysis, 2021
14.20.2.1. By Application
14.21. New Zealand
14.21.1. Pricing Analysis
14.21.2. Market Share Analysis, 2021
14.21.2.1. By Application
14.22. GCC Countries
14.22.1. Pricing Analysis
14.22.2. Market Share Analysis, 2021
14.22.2.1. By Application
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Application
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Medtronic
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.1.5.2. Product Strategy
16.1.1.5.3. Channel Strategy
16.1.2. Integra LifeSciences
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.2.5.2. Product Strategy
16.1.2.5.3. Channel Strategy
16.1.3. Raumedic AG
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.3.5.2. Product Strategy
16.1.3.5.3. Channel Strategy
16.1.4. Sophysa
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.4.5.2. Product Strategy
16.1.4.5.3. Channel Strategy
16.1.5. Spiegelberg GmbH
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.5.5.2. Product Strategy
16.1.5.5.3. Channel Strategy
16.1.6. Natus Medical
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.6.5.2. Product Strategy
16.1.6.5.3. Channel Strategy
16.1.7. Gaeltec Devices
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.7.5.2. Product Strategy
16.1.7.5.3. Channel Strategy
16.1.8. Neural Analytics
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.8.5.2. Product Strategy
16.1.8.5.3. Channel Strategy
17. Assumptions & Acronyms Used
18. Research Methodology

List of Tables

Table 1: Global Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 3: North America Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 4: North America Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 5: Latin America Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 6: Latin America Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 7: Europe Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 8: Europe Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 9: East Asia Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 10: East Asia Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 11: South Asia Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 12: South Asia Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 13: Oceania Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Oceania Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 15: MEA Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 16: MEA Neurology Patient Monitoring Market Value (US$ Mn) Forecast by Application, 2017-2032


• 英文レポート名:Neurology Patient Monitoring Market Forecast by Application (Trauma, CSF Management, Migraine, Stroke, EEG) and by Region - 2022 to 2032
• 日本語訳:神経系患者モニタリングのグローバル市場(2022ー2031年):外傷、髄液管理、偏頭痛、脳卒中、脳波
• レポートコード:MRC2301F0009お問い合わせ(見積依頼・ご注文・質問)